ArticleMolecular cancer therapeutics2013
TLR4 is a novel determinant of the response to paclitaxel in breast cancer.
Sandeep Rajput et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
100 papers cite itlatest 60 shown
this papertrialcites it